Device Hips

M2a - Modular Head Hip System

Payments companies reported to CMS as associated with M2a - Modular Head Hip System. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.

$162Kassociated payments (2023-2025)
10clinicians with associated payments
1company reporting

By year

2023 $43K
2024 $106K
2025 $13K

Payments reported as associated with M2a - Modular Head Hip System, per program year, as reported to CMS.

Who makes it

Specialties most often involved

Orthopaedic Surgery $71K
Anatomic Pathology & Clinical Pathology $59K
Family Medicine $13K
Adult Reconstructive Orthopaedic Surgery $12K
Anatomic Pathology $7,500

Where the associated payments went, by the receiving clinician's specialty.

Clinicians most associated with M2a - Modular Head Hip System

These are the largest totals companies reported as associated with M2a - Modular Head Hip System. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.

ClinicianLocationSpecialtyAssociated payments (2023-2025)
Scott Nelson Los Angeles, CA Anatomic Pathology & Clinical Pathology $59,150.00
Robert Schmidt Fort Worth, TX Orthopaedic Surgery $56,875.00
Robert Schmidt Rossford, OH Family Medicine $12,800.00
David Scott Spokane, WA Adult Reconstructive Orthopaedic Surgery $8,000.00
Francis Gannon Houston, TX Anatomic Pathology $7,500.00
Raymond Robinson Seattle, WA Orthopaedic Surgery $5,200.00
Mitchell Sheinkop Chicago, IL Orthopaedic Surgery $4,000.00
Carl Freeman Jacksonville, FL Orthopaedic Surgery $3,750.00
Alexander Tauchen Lincolnshire, IL Adult Reconstructive Orthopaedic Surgery $3,500.00
Douglas Chonko Columbus, OH Orthopaedic Surgery $1,000.00

Prescribed M2a - Modular Head Hip System?

See what its makers reported for your doctor. Two steps, private, no account.

Check my doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.